Chinese early-stage investor Glory Ventures has closed its third renminbi-denominated fund at RMB682 million ($96 million) and also reached a first close of its second US dollar vehicle.
The size of the first close for the US dollar fund - which has an overall target of $100 million - was not disclosed. It has taken Glory six months to reach the first close, while the entire fundraising...
KKR has offered to acquire up to 9% of First Gen Corporation, a power plant operator in the Philippines, for PHP7.29 billion ($144 million).
Japan’s Beyond Next Ventures has led a JPY800 billion ($7.4 million) Series A round for local cell-based agricultural technology specialist IntegriCulture.
Chinese drug developer Jiangsu Atom Bioscience & Pharmaceutical has raised $30 million in Series B funding led by Sequoia Capital China and Hong Kong-listed Livzon Pharmaceutical Group.
Hillhouse Capital has led an extended Series A round of funding worth $50 million for Deepexi, a Chinese start-up that provides a suite of smart data services to enterprise customers.